Literature DB >> 10510675

Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).

R Luthra1, A H Sarris, S Hai, A V Paladugu, J E Romaguera, F F Cabanillas, L J Medeiros.   

Abstract

We describe the usefulness of a real-time polymerase chain reaction (PCR) assay for detection of the t(11;14)(q13;q32), most commonly present in mantle cell lymphoma (MCL). This assay is based on the 5'-->3' exonuclease activity of Taq polymerase, which cleaves an internal probe labeled with a reporter dye at its 5' end and a quencher dye at its 3' end during PCR. The real-time t(11;14) PCR assay was established using DNA from a case of MCL with the t(11;14), amplifiable using conventional PCR and primers specific for the major translocation cluster (MTC) region of the bcl-1 locus and the immunoglobulin heavy chain joining region gene (JH). The specificity was determined by analyzing DNA from 82 cases: 50 MCL, 27 other types of non-Hodgkin lymphoma (NHL), and 5 reactive lymphoid proliferations. The real-time t(11;14) PCR results were correlated with data obtained by a conventional PCR assay. By using the real-time assay, bcl-1 MTC/JH DNA fusion sequences were detected in 25 of 50 MCLs but not in other NHLs or reactive lymphoid proliferations. Concordance between real-time and conventional PCR methods for MCL was 96% and for all samples was 98%. The results demonstrate that this real-time PCR method to detect bcl-1 MTC/JH DNA fusion sequences is specific and reliable. In addition, the results are available immediately following amplification, without standard post-PCR manipulations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510675     DOI: 10.1093/ajcp/112.4.524

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.

Authors:  Joaquin Martinez-Lopez; Pilar Martinez-Sanchez; Ramon Garcia-Sanz; Maria Eugenia Sarasquete; Rosa Ayala; Marcos Gonzalez; Jose Manuel Bautista; David Gonzalez; Jesus San Miguel; Guillermo Garcia-Effron; Juan Jose Lahuerta
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

2.  Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.

Authors:  R Suzuki; K Takemura; M Tsutsumi; S Nakamura; N Hamajima; M Seto
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.

Authors:  Zaher I Chakhachiro; Rima M Saliba; Grace-Julia Okoroji; Martin Korbling; Amin M Alousi; Oran Betul; Paolo Anderlini; Stefan O Ciurea; Uday Popat; Richard Champlin; Barry I Samuels; L Jeffrey Medeiros; Carlos Bueso-Ramos; Issa F Khouri
Journal:  Cancer       Date:  2013-06-17       Impact factor: 6.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.